Literature DB >> 23805336

Bypass surgery in limb salvage: inflow procedures.

Jean Bismuth1, Cassidy Duran.   

Abstract

Proper management of lower-extremity inflow vessel disease is critical to the success of distal interventions. Aortobifemoral bypass is the most effective means of treating aortoiliac disease, but this invasive procedure is not always ideal for a patient population that often has diffuse vascular disease and multiple comorbidities. Technologic advances and increasing experience have fundamentally altered the management algorithm for lower-extremity vascular lesions, and endovascular options have become the first-line therapy for Trans-Atlantic Inter-Society Guidelines (TASC) class A and B lesions. In fact, an endovascular first approach is being endorsed even for highly complex TASC C and even TASC D lesions. Other alternatives include minimally invasive (laparoscopic or robotic) options or extra-anatomic bypass procedures. Inadequate outflow can compromise any inflow procedure, but inflow treatment failures are the crux of all limb salvage in patients with lower-extremity vascular disease.

Entities:  

Keywords:  Iliac; aortoiliac; artery; inflow; ischemia; occlusive

Mesh:

Year:  2013        PMID: 23805336      PMCID: PMC3693517          DOI: 10.14797/mdcj-9-2-66

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  11 in total

1.  Robotic vascular surgery, 150 cases.

Authors:  P Stádler; L Dvoracek; P Vitasek; P Matous
Journal:  Int J Med Robot       Date:  2010-12       Impact factor: 2.547

2.  Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions.

Authors:  Irfan I Galaria; Mark G Davies
Journal:  Ann Vasc Surg       Date:  2005-05       Impact factor: 1.466

3.  Long-term outcomes and predictors of iliac angioplasty with selective stenting.

Authors:  Toshifumi Kudo; Fiona A Chandra; Samuel S Ahn
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

4.  A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease.

Authors:  Bibombe P Mwipatayi; Shannon Thomas; Jackie Wong; Suzanna E L Temple; Vikram Vijayan; Mark Jackson; Sally A Burrows
Journal:  J Vasc Surg       Date:  2011-09-09       Impact factor: 4.268

Review 5.  Robotic aortic surgery.

Authors:  Cassidy Duran; Elika Kashef; Hosam F El-Sayed; Jean Bismuth
Journal:  Methodist Debakey Cardiovasc J       Date:  2011 Jul-Sep

6.  The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice.

Authors:  Chetan P Huded; Philip P Goodney; Richard J Powell; Brian W Nolan; Eva M Rzucidlo; Samuel T Simone; Daniel B Walsh; David H Stone
Journal:  J Vasc Surg       Date:  2012-01-05       Impact factor: 4.268

7.  An optimal inflow procedure for multi-segmental occlusive arterial disease: ilio-femoral versus aorto-bifemoral bypass.

Authors:  G Zukauskas; H Ulevicius; E Janusauskas
Journal:  Cardiovasc Surg       Date:  1998-06

8.  Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions.

Authors:  Carlos H Timaran; Trent L Prault; Scott L Stevens; Michael B Freeman; Mitchell H Goldman
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

9.  Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease.

Authors:  Sachinder Singh Hans; Debbie DeSantis; Rizwan Siddiqui; Michael Khoury
Journal:  Surgery       Date:  2008-10       Impact factor: 3.982

10.  Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease.

Authors:  M A Passman; L M Taylor; G L Moneta; J M Edwards; R A Yeager; D B McConnell; J M Porter
Journal:  J Vasc Surg       Date:  1996-02       Impact factor: 4.268

View more
  1 in total

1.  Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer.

Authors:  Yanyan Qi; Xiangyan Yao; Beibei Zhang; Xianhui DU
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.